CBR4

Across TCGA pan-cancer cohorts, CBR4 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated CBR4 data layer compared with 24 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher CBR4 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated CBR4 expression acts as an unfavorable survival marker, although some lineages such as COAD and CCRCC show a favorable association.

COAD, CCRCC, and PDAC are the cancer types where CBR4 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Median	II,III,IV	1.000	0.910	.011	42	view →
CCRCC	OS	Median	All	1.000	0.679	.013	15	view →
PDAC	DFS	Quartile	All	0.432	0.238	.019	9	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

CBR4–COAD (DFS)

Open the COAD breakdown →